General MedicationsORALGeneric

GO-EVAC

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Standard Dose

236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview GO-EVAC is listed in Drugs@FDA under application 073433 (ANDA).

Marketing status: Discontinued Active ingredient POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS Form and strength FOR SUSPENSION;ORAL - 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT Sponsor VINTAGE PHARMS Submission history Latest submission status date: 1999-03-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview GO-EVAC is listed in Drugs@FDA under application 073433 (ANDA). Marketing status: Discontinued Active ingredient POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS Form and strength FOR SUSPENSION;ORAL - 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT Sponsor VINTAGE PHARMS Submission history Latest submission status date: 1999-03-23 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.